Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/targeted-tablet-approved-esr1-breast-cancer-2026a10005xy?src=rss

Author :

Publish date : 2026-02-25 14:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Targeted Tablet Approved for ESR1 Breast Cancer

Trump Touched on Healthcare in State of the Union Speech: Here’s What He Said

Cream Cheese Recall; Nobel Winner Resigns Over Epstein Ties; Cadaver Fat in Surgery

Related Posts

Dementia Risk May Be Linked to One’s Outlook, Study Suggests

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers look into island’s health benefits

‘Doctors thought my endometriosis was IBS’

Autoimmune Disease in Parent Tied to Allergy Risk in Child

High-Flow Oxygen Slightly Reduces Intubation, Not Mortality

Dementia Risk May Be Linked to One’s Outlook, Study Suggests

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers look into island’s health benefits

‘Doctors thought my endometriosis was IBS’

Autoimmune Disease in Parent Tied to Allergy Risk in Child

High-Flow Oxygen Slightly Reduces Intubation, Not Mortality

Can One Therapy Session Make a Difference? Experts Say Yes, With the Right Mindset

FDA Approves First Farxiga Generics for Type 2 Diabetes

Categories

Archives